
zzso zzso is an analog of zzso with limited water zzso which has shown significant zzso activity in a variety of human solid tumor zzso A Phase I trial using a soluble zzso of zzso given as a 72-hour continuous infusion, has been zzso Thirty-one patients with resistant zzso received zzso zzso at three week zzso The zzso zzso zzso zzso was 45 zzso zzso was the dose limiting zzso with few significant zzso zzso Minor responses were seen in zzso zzso zzso studies of zzso zzso zzso zzso showed substantial zzso zzso with a predicted zzso of 36 zzso A phase zzso trial of the same zzso of zzso is ongoing in zzso zzso zzso and zzso are the zzso dose limiting zzso Evidence of zzso activity has been seen in zzso zzso A Phase II trial in previously zzso zzso breast cancer is also zzso A Phase I trial of a zzso zzso zzso not yet completed, is better tolerated with a zzso zzso 45 zzso as a 72-hour continuous zzso Evidence of zzso activity has also been zzso 

